These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. Arthur M; Brisson-Noël A; Courvalin P J Antimicrob Chemother; 1987 Dec; 20(6):783-802. PubMed ID: 3326871 [TBL] [Abstract][Full Text] [Related]
3. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci. Barry AL; Fuchs PC; Brown SD Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807 [TBL] [Abstract][Full Text] [Related]
4. [Macrolides, lincosamides, streptogramines (MLS): mechanisms of action and resistance]. Ungureanu V Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):131-8. PubMed ID: 21553477 [TBL] [Abstract][Full Text] [Related]
5. Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. Jensen LB; Frimodt-Møller N; Aarestrup FM FEMS Microbiol Lett; 1999 Jan; 170(1):151-8. PubMed ID: 9919664 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of resistance phenotypes and genotypes to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in Tunisian Bone Marrow Transplant Center. Bouchami O; Achour W; Ben Hassen A Pathol Biol (Paris); 2011 Aug; 59(4):199-206. PubMed ID: 19481372 [TBL] [Abstract][Full Text] [Related]
7. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance. Reyes J; Hidalgo M; Díaz L; Rincón S; Moreno J; Vanegas N; Castañeda E; Arias CA Int J Infect Dis; 2007 Jul; 11(4):329-36. PubMed ID: 17320446 [TBL] [Abstract][Full Text] [Related]
8. Azithromycin and erythromycin susceptibility and macrolide resistance genes in Prevotella from patients with periodontal disease. Arredondo A; Blanc V; Mor C; Nart J; León R Oral Dis; 2019 Apr; 25(3):860-867. PubMed ID: 30667163 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci. Mlynarczyk B; Mlynarczyk A; Kmera-Muszynska M; Majewski S; Mlynarczyk G Mini Rev Med Chem; 2010 Sep; 10(10):928-37. PubMed ID: 20370697 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106 [TBL] [Abstract][Full Text] [Related]
11. Life-threatening invasive Helcococcus kunzii infections in intravenous-drug users and ermA-mediated erythromycin resistance. Woo PC; Tse H; Wong SS; Tse CW; Fung AM; Tam DM; Lau SK; Yuen KY J Clin Microbiol; 2005 Dec; 43(12):6205-8. PubMed ID: 16333132 [TBL] [Abstract][Full Text] [Related]
12. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208 [TBL] [Abstract][Full Text] [Related]
14. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Ambrose KD; Nisbet R; Stephens DS Antimicrob Agents Chemother; 2005 Oct; 49(10):4203-9. PubMed ID: 16189099 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens. Szczuka E; Makowska N; Bosacka K; Słotwińska A; Kaznowski A Folia Microbiol (Praha); 2016 Mar; 61(2):143-7. PubMed ID: 26253583 [TBL] [Abstract][Full Text] [Related]
16. High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. Okamoto H; Tateda K; Ishii Y; Matsumoto T; Kobayashi T; Miyazaki S; Yamaguchi K J Infect Chemother; 2002 Mar; 8(1):28-32. PubMed ID: 11957116 [TBL] [Abstract][Full Text] [Related]
17. Report of ribosomal RNA methylase gene erm(B) in multidrug-resistant Campylobacter coli. Qin S; Wang Y; Zhang Q; Zhang M; Deng F; Shen Z; Wu C; Wang S; Zhang J; Shen J J Antimicrob Chemother; 2014 Apr; 69(4):964-8. PubMed ID: 24335515 [TBL] [Abstract][Full Text] [Related]
18. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Gulay Z; Ozbek OA; Bicmen M; Gur D Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. Eady EA; Coates P; Ross JI; Ratyal AH; Cove JH J Antimicrob Chemother; 2000 Aug; 46(2):205-13. PubMed ID: 10933642 [TBL] [Abstract][Full Text] [Related]
20. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]